Literature DB >> 19249306

Chemical evaluation of fatty acid desaturases as drug targets in Trypanosoma cruzi.

Andrés Alloatti1, Sebastián A Testero, Antonio D Uttaro.   

Abstract

Four positional isomers of Thiastearate (TS) and Isoxyl (Thiocarlide) were assayed as fatty acid desaturase inhibitors in Trypanosoma cruzi epimastigotes. 9-TS did not exert a significant effect on growth of T. cruzi, nor on the fatty acid profile of the parasite cells. One hundred micromolars of 10-TS totally inhibited growth, with an effective concentration for 50% growth inhibition (EC(50)) of 3.0+/-0.2microM. Growth inhibition was reverted by supplementing the culture media with oleate. The fatty acid profile of treated cells revealed that conversion of stearate to oleate and palmitate to palmitoleate were drastically reduced and, as a consequence, the total level of unsaturated fatty acids decreased from 60% to 32%. Isoxyl, a known inhibitor of stearoyl-CoA Delta9 desaturase in mycobacteria, had similar effects on T. cruzi growth (EC(50) 2.0+/-0.3microM) and fatty acid content, indicating that Delta9 desaturase was the target of both drugs. 12- and 13-TS were inhibitors of growth with EC(50) values of 50+/-2 and 10+/-3microM, respectively, but oleate or linoleate were unable to revert the effect. Both drugs increased the percentage of oleate and palmitate in the cell membrane and drastically reduced the content of linoleate from 38% to 16% and 12%, respectively, which is in agreement with a specific inhibition of oleate Delta12 desaturase. The absence of corresponding enzyme activity in mammalian cells and the significant structural differences between trypanosome and mammalian Delta9 desaturases, together with our results, highlight these enzymes as promising targets for selective chemotherapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249306     DOI: 10.1016/j.ijpara.2009.01.011

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  6 in total

1.  Synergistic effect of inhibitors of fatty acid desaturases on Trypanosoma parasites.

Authors:  Andrés Alloatti; Karina E J Tripodi; Antonio D Uttaro
Journal:  Parasitol Res       Date:  2013-06-25       Impact factor: 2.289

Review 2.  Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexans.

Authors:  Srinivasan Ramakrishnan; Mauro Serricchio; Boris Striepen; Peter Bütikofer
Journal:  Prog Lipid Res       Date:  2013-07-01       Impact factor: 16.195

3.  Genetic and chemical evaluation of Trypanosoma brucei oleate desaturase as a candidate drug target.

Authors:  Andrés Alloatti; Shreedhara Gupta; Melisa Gualdrón-López; Mariana Igoillo-Esteve; Paul A Nguewa; Gladys Deumer; Pierre Wallemacq; Silvia G Altabe; Paul A M Michels; Antonio D Uttaro
Journal:  PLoS One       Date:  2010-12-06       Impact factor: 3.240

4.  Comparative analysis of tumor-associated vascular changes following TACE alone or in combination with sorafenib treatment in HCC: A retrospective study.

Authors:  Ligang Chen; Yifei Zheng; Hongjian Zhang; Heng Pan; Qiusong Liu; Xu Zhou; Wei Wei; Yun Liu; Maochuan Zhen; Jinling Wang; Jianyin Zhou; Yilin Zhao
Journal:  Oncol Lett       Date:  2018-07-02       Impact factor: 2.967

5.  A Histoplasma capsulatum Lipid Metabolic Map Identifies Antifungal Targets.

Authors:  Daniel Zamith-Miranda; Heino M Heyman; Meagan C Burnet; Sneha P Couvillion; Xueyun Zheng; Nathalie Munoz; William C Nelson; Jennifer E Kyle; Erika M Zink; Karl K Weitz; Kent J Bloodsworth; Geremy Clair; Jeremy D Zucker; Jeremy R Teuton; Samuel H Payne; Young-Mo Kim; Morayma Reyes Gil; Erin S Baker; Erin L Bredeweg; Joshua D Nosanchuk; Ernesto S Nakayasu
Journal:  mBio       Date:  2021-11-23       Impact factor: 7.867

6.  Quantitative proteome and phosphoproteome analyses highlight the adherent population during Trypanosoma cruzi metacyclogenesis.

Authors:  Juliana C Amorim; Michel Batista; Elizabeth S da Cunha; Aline C R Lucena; Carla V de Paula Lima; Karla Sousa; Marco A Krieger; Fabricio K Marchini
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.